Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P30044 (
antioxidant enzyme
)
8,037
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Manganese superoxide dismutase
(
MnSOD
) is a nuclear encoded primary
antioxidant enzyme
localized in mitochondria. Because expression of
MnSOD
plays a major role in maintaining cellular redox status and reactive oxygen species are known to play a role in signal transduction and carcinogenesis, we investigated the role of
MnSOD
in the development of cancer using a two-stage [7,12-dimethylbenz(a)-anthracene plus 12-O-tetradecanoylphorbol-13-acetate (TPA)] skin carcinogenesis model. Female transgenic mice expressing the human
MnSOD
gene in the skin and their nontransgenic counterparts were used in this study. Pathological examination demonstrated significant reduction of papilloma formation in transgenic mice. Quantitative analysis of 4-hydroxy-2-nonenal-modified proteins showed greater accumulation of oxidative damage products in nontransgenic compared with transgenic mice, and this oxidative damage was demonstrated to be present in both mitochondria and nucleus. TPA increased activator protein-1 (AP-1) binding activity within 6 h in nontransgenic mice, but increased AP-1 binding activity was delayed in the transgenic mice. Electrophoretic mobility shift assay, transcription of the target genes, and Western analysis studies indicated that the increased AP-1 binding activity was attributable to induction of the Jun but not the Fos protein families. Overexpression of
MnSOD
selectively inhibited the TPA-induced activation of protein kinase Cepsilon and prevented subsequent activation of c-Jun NH(2)-terminal kinase in response to TPA. Overall, these results indicate that
MnSOD
regulates both cellular redox status and selectively modulates PKCepsilon signaling, thereby delaying AP-1 activation and inhibiting tumor promotion, resulting in reduction of tumors in
MnSOD
transgenic mice.
...
PMID:Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. 1150 57
Manganese superoxide dismutase
(
MnSOD
) is an
antioxidant enzyme
capable of neutralizing superoxide anion molecules. In previous studies it has been suggested to suppress both tumour proliferation and apoptosis. This study investigated 65 invasive, 50 in situ and 19 benign hyperplastic breast lesions for its immunohistochemical expression.
MnSOD
expression was also tested with in situ hybridization. To study cell proliferation, apoptosis and their association with
MnSOD
expression the neoplastic breast lesions were immunostained with a monoclonal antibody to Ki-67 and the extent of apoptosis in them was determined by the TUNEL method. 32/65 (49%) of the invasive ductal carcinomas, 41/50 (82%) of the in situ and 15/19 (79%) of the benign hyperplasias expressed the
MnSOD
protein. There were significantly more
MnSOD
positive cases in in situ carcinoma and in benign hyperplasia than in invasive carcinoma (p=0.00016 and p=0.022, respectively). Positivity was also more frequently found in non-neoplastic ductal and acinar epithelial cells than in invasive carcinoma. On the other hand, neoplastic epithelial cells of invasive and in situ carcinoma showed strong positivity more often than the epithelial cells of benign hyperplasia or non-neoplastic epithelium. In breast lesions,
MnSOD
positivity did not associate with proliferation or apoptosis. The lower frequency of
MnSOD
positive cases in invasive breast carcinoma suggests that the lack of its expression might contribute to the development of an invasive breast carcinoma phenotype and that it could in this way operate as a tumour suppressor gene, as previously suggested.
...
PMID:MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. 1159 93
Phytoestrogens such as the soy isoflavonoid daidzein have potential health benefits. The antioxidant properties of phytoestrogens are considered to be responsible in part for their protective effects. The
antioxidant enzyme
(AOE) system plays an important role in the defense of cells against oxidative insults. To determine whether flavonoids can exert antioxidative effects not only directly but also indirectly by modulating the AOE system, we investigated the influence of the flavonoid daidzein on the expression of different AOE. Daidzein treatment of hepatoma H4IIE cells increased catalase mRNA expression two- to threefold. Expression levels of copper zinc superoxide dismutase (CuZnSOD) were not affected by exposure to daidzein.
Manganese superoxide dismutase
(
MnSOD
) mRNA expression levels decreased slightly and glutathione peroxidase (GPx) levels increased slightly after daidzein exposure. Changes in AOE mRNA expression levels were significant at 300 micromol/L daidzein. To elucidate the mechanisms underlying the strong increase in catalase mRNA, transfection experiments were performed. Transient transfection of hepatoma cells with reporter plasmids containing different parts of the upstream region of the catalase gene showed a significant one- to threefold increase in reporter gene activity after daidzein exposure. This indicates that daidzein can directly activate the rat catalase promoter region. Despite the increase in catalase mRNA, daidzein pretreatment of cells did not protect against oxidative stress resulting from H(2)O(2) exposure. On the contrary, daidzein itself exerted a mild oxidative stress. In conclusion, the changes in the AOE system provoked by daidzein affected the oxidant rather than the antioxidant properties of daidzein.
...
PMID:The phytoestrogen daidzein affects the antioxidant enzyme system of rat hepatoma H4IIE cells. 1188 May 57
Manganese superoxide dismutase
(
MnSOD
) has been shown to suppress the development of cancer. Tamoxifen (TAM), a nonsteroidal anti-estrogen that is widely used in chemotherapy, is known to be a modulator of antioxidant status. However, the mechanism by which TAM mediates
antioxidant enzyme
induction remains unclear. In this study we investigated TAM enhancement of
MnSOD
induction by TNF-alpha. The results show that co-treatment with TAM and TNF-alpha increases the
MnSOD
promoter/enhancer driven luciferase activity,
MnSOD
mRNA and protein levels. Interestingly, co-treatment with TAM and TNF-alpha drastically decreases the binding activity of the p50/p50 homodimer and increases that of the p50/p65 heterodimer compared to TNF-alpha alone. This change in DNA binding could not be attributed to a decrease in the level of p50, its precursor, p105, or its inhibitors. Furthermore, TAM did not enhance degradation of IkappaB-alpha. These results suggest that p50/p50 homodimer may act as an inhibitory complex of
MnSOD
expression. Modulation of the DNA binding activity in favor of the p50/p65 complex may enhance NF-kappaB mediated induction of
MnSOD
by TAM. These findings reveal a potential novel mechanism for the induction of the human
MnSOD
gene.
...
PMID:Tamoxifen enhancement of TNF-alpha induced MnSOD expression: modulation of NF-kappaB dimerization. 1203 62
Ionizing radiation induces the production of superoxide radicals (O(2)(-).) which play a role in apoptosis generation.
Manganese superoxide dismutase
(
MnSOD
) is a mitochondrial
antioxidant enzyme
involved in scavenging O(2)(-). This study is designed to investigate the effect of
MnSOD
on ionizing radiation-induced apoptosis. The eukaryotic expressing vector, pHbetaAPr-3p-neo, containing sense and antisense human
MnSOD
cDNA have been introduced into Chinese hamster ovary (CHO) cells respectively by gene transfection method and the
MnSOD
overexpressing cell lines have been used in this study. It was found that the cell clone overexpressing sense
MnSOD
could effectively prevent 8 Gy X-ray-induced apoptosis in CHO cells, whereas the clone overexpressing antisense
MnSOD
increased their sensitivity. Further studies also demonstrated that alterations of mitochondrial membrane potential (deltapsi(m)) may play an important role in the regulatory mechanisms of
MnSOD
on ionizing radiation-induced apoptosis.
...
PMID:Regulation of Ionizing Radiation-induced Apoptosis by MnSOD Gene Transfection. 1217 93
Manganese superoxide dismutase
(
MnSOD
) is a critical
antioxidant enzyme
that protects against superoxide anion generated as a consequence of normal cellular respiration, as well as during the inflammatory response. By employing dimethyl sulfate in vivo footprinting, we have previously identified ten basal protein binding sites within the
MnSOD
promoter. On the basis of consensus sequence comparison and in vitro footprinting data, one would predict that Sp1 might occupy five of these binding sites. To address these findings in the context of the nucleoprotein environment, we first utilized chromatin immunoprecipitation (ChIP) to demonstrate the nuclear association of Sp1 with the
MnSOD
promoter region. To identify the precise location of Sp1 binding, we have modified the original protein position identification with nuclease tail (PIN*POINT) methodology, providing an approach to establish both the identity and binding occupancy of Sp1 in the context of the endogenous
MnSOD
promoter. These data, coupled with site-directed mutagenesis, demonstrate the functional importance of two of the Sp1 binding sites in the stimulus-specific regulation of
MnSOD
gene expression. We feel that the combination of ChIP and PIN*POINT analysis allows unequivocal identification and localization of protein/DNA interactions in vivo, specifically the demonstration of Sp1 with the
MnSOD
promoter.
...
PMID:PIN*POINT analysis on the endogenous MnSOD promoter: specific demonstration of Sp1 binding in vivo. 1238 80
Free radical-mediated mechanisms of cellular damage have been implicated in the early stages of spinal cord injury (SCI).
Manganese superoxide dismutase
(
MnSOD
) is a potent scavenger of superoxide radicals and likely serves an important cytoprotective role in preventing cellular damage after SCI. We have evaluated the expression of
MnSOD
to address its role during the early events of SCI using a well-established rat contusion model. Northern analysis showed a rapid induction of
MnSOD
mRNA between 2 and 6 h post injury. Observed time-dependent increases in
MnSOD
message was maximal 6 h post injury over that of
MnSOD
mRNA levels induced by laminectomy alone. Immunoblot and immunohistochemical analysis demonstrated increased expression of
MnSOD
protein 24 h after SCI with localization primarily within neurons. Interestingly, laminectomy alone also caused an induction of
MnSOD
gene and protein expression. To evaluate one potential mechanism of
MnSOD
induction, we microinjected the naive spinal cord with IL-1beta, which caused a similar fold induction of
MnSOD
mRNA levels by 6 h as observed with SCI, thus implicating it as a potential inducer of
MnSOD
during SCI. In summary, these results demonstrate that this potent cytoprotective
antioxidant enzyme
is rapidly and significantly induced as a consequence of SCI.
...
PMID:Induction of manganese superoxide dismutase in acute spinal cord injury. 1248 19
Exercise improves cardioprotection against ischemia-reperfusion in young animals but has not been investigated in older animals, which represent the population most likely to suffer an ischemic event. Therefore, we sought to determine the effects of aging on exercise-induced cardioprotection. Young, middle-aged, and old (4, 12, and 21 mo old) male Fischer 344 rats ran 60 min at 70-75% of maximum oxygen consumption. Twenty-four hours postexercise, isolated perfused working hearts underwent 22.5 min of global ischemia and then 30 min of recovery (reperfusion). Compared with sedentary rats (n = 8-9 rats/group), recovery of function (cardiac output x systolic pressure) improved after exercise (n = 9 rats/group) by 40% at 4 mo, 78% at 12 mo, and 59% at 21 mo. Exercise increased inducible heat shock protein 70 expression 105% at 4 mo but only 27% at 12 mo and 24% at 21 mo. Catalase activity progressively increased with age (P < 0.05) and was increased by exercise at 4 mo (26%) and 21 mo (19%).
Manganese superoxide dismutase
activity was increased by exercise only at 21 mo (45%). No exercise-related change in any
antioxidant enzyme
was observed at 12 mo. We conclude that exercise can enhance cardioprotection regardless of age, but the cardioprotective protein phenotype changes with age.
...
PMID:Exercise improves postischemic function in aging hearts. 1264 77
Hypertension caused by angiotensin II is characterized by an increase in tissue oxidant stress as evidenced by increased quantities of reactive oxygen and nitrogen species.
Manganese superoxide dismutase
(
MnSOD
) is a key mitochondrial
antioxidant enzyme
that is inactivated in conditions of oxidant stress by reacting with peroxynitrite to form 3-nitrotyrosine in its active site. The increase in 3-nitrotyrosine content in
MnSOD
in the kidney of angiotensin II-infused rats was assessed in this study by immunohistochemistry, Western blotting, immunoprecipitation, and HPLC with UV detection (HPLC-UV).
MnSOD
activity decreased approximately 50% in angiotensin II-infused rat kidneys (24 +/- 4.6 vs. 11 +/- 5.2 U/mg) without a change in protein expression. Immunohistochemical staining showed 3-nitrotyrosine predominantly in distal tubules and collecting duct cells in the angiotensin II-infused rat kidneys. By two-photon microscopy, 3-nitrotyrosine colocalized with
MnSOD
. Total 3-nitrotyrosine content in kidney homogenates was increased in angiotensin II-infused rat kidney [3.2 +/- 1.9 (sham treated) vs. 9.5 +/- 2.3 ng/mg protein by HPLC-UV detection]. With tracer amounts of tyrosine-nitrated recombinant
MnSOD
, the most sensitive technique to detect tyrosine nitration of
MnSOD
was immunoprecipitation from tissue with anti-
MnSOD
antibody, followed by detection of 3-nitrotyrosine by Western blotting or HPLC. By HPLC, 3-nitrotyrosine content of kidney
MnSOD
increased 13-fold after angiotensin II infusion, representing an increase from approximately one-twentieth to one-fifth of the total 3-nitrotyrosine content in sham-treated and angiotensin II-infused rat kidney, respectively. Angiotensin II-induced hypertension is accompanied by increased tyrosine nitration of
MnSOD
, which, because it inactivates the enzyme, may contribute to increased oxidant stress in the kidney.
...
PMID:Quantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin II-infused rat kidney. 1279 89
Manganese superoxide dismutase
(
MnSOD
) is an
antioxidant enzyme
with tumor suppressor activity; however, the molecular mechanisms of
MnSOD
antitumor effects remain unclear. We hypothesized that
MnSOD
activity in cancer cells might cause downstream changes in the expression of other tumor suppressor genes. To determine whether maspin, a tumor suppressor gene that inhibits breast cancer cell invasion and metastasis, might be a target of
MnSOD
, we forced
MnSOD
expression in several human breast and prostate cancer cell lines by adenovirus-mediated gene transfer and measured maspin mRNA expression. Forced expression of
MnSOD
caused maspin mRNA to accumulate in a dose-dependent manner in both human breast and prostate cancer cells. Normal p53 was not necessary to mediate the effect of
MnSOD
because
MnSOD
up-regulated maspin in cells that harbor wild-type p53 and in cells that harbor mutant p53. Moreover, the effects of
MnSOD
on maspin were not due to demethylation of the maspin promoter. Analyses of maspin promoter activity, transcriptional run-on, and mRNA stability showed that maspin mRNA stability was the major mechanism for maspin up-regulation by
MnSOD
. Our findings identify a mechanism underlying
MnSOD
antitumor effects and provide evidence to support
MnSOD
as a genetic therapy in the treatment of human breast and prostate cancers.
...
PMID:MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells. 1458 Mar 25
<< Previous
1
2
3
4
5
6
Next >>